Literature DB >> 15809203

Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease.

Othmar Ludwiczek1, Arthur Kaser, Daniela Novick, Charles A Dinarello, Menachem Rubinstein, Herbert Tilg.   

Abstract

OBJECTIVES: Interleukin 18 (IL-18) is a proinflammatory cytokine and a member of the IL-1 family. Animal models and investigations in humans point to an important role for this cytokine in inflammatory bowel diseases (IBD). IL-18 binding protein (IL-18BP) is a naturally occurring antagonist of IL-18. Methods. In this study, we measured IL-18 and IL-18BP plasma concentrations and spontaneous release in cultures of colonic explants from healthy subjects (n = 41), patients with Crohn's disease (CD, n = 135), and patients with ulcerative colitis (UC, n = 93).
RESULTS: Both CD and UC patients had higher IL-18BP plasma levels than controls. Plasma levels of free, unbound IL-18 were significantly elevated in CD patients compared to healthy controls, but not in UC patients. Colonic explant cultures from inflamed areas in IBD patients released significantly higher levels of IL-18 than non-inflamed areas and controls. IL-18BP levels from the same cultures were below the detection limit over a culture period of 24 h.
CONCLUSIONS: Our results confirm the importance of IL-18 in the pathogenesis of IBD and suggest that especially in CD, IL-18BP might be produced in insufficient quantities to counteract the effects of endogenous IL-18.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809203

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  17 in total

Review 1.  T-cell activation in the intestinal mucosa.

Authors:  Dina Montufar-Solis; Tomas Garza; John R Klein
Journal:  Immunol Rev       Date:  2007-02       Impact factor: 12.988

2.  Stimulatory and costimulatory effects of IL-18 directed to different small intestinal CD43 T cell subsets.

Authors:  Dina Montufar-Solis; Heuy-Ching Wang; John R Klein
Journal:  J Leukoc Biol       Date:  2007-08-16       Impact factor: 4.962

3.  Interleukin-18 is increased only in a minority of patients with active Crohn's disease.

Authors:  C Schmidt; T Giese; R Goebel; M Schilling; T Marth; A Ruether; S Schreiber; S Zeuzem; S C Meuer; A Stallmach
Journal:  Int J Colorectal Dis       Date:  2007-02-21       Impact factor: 2.571

4.  Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions.

Authors:  Michael Thiele; Randolf J Kerschbaumer; Frederick W K Tam; Dirk Völkel; Patrice Douillard; Alexander Schinagl; Harald Kühnel; Jennifer Smith; John P McDaid; Gurjeet Bhangal; Mei-Ching Yu; Charles D Pusey; H Terence Cook; Josef Kovarik; Erica Magelky; Atul Bhan; Manfred Rieger; Geert C Mudde; Hartmut Ehrlich; Bernd Jilma; Herbert Tilg; Alexander Moschen; Cox Terhorst; Friedrich Scheiflinger
Journal:  J Immunol       Date:  2015-07-24       Impact factor: 5.422

5.  Interleukin-18 binding protein in the sera of patients with Wegener's granulomatosis.

Authors:  D Novick; D Elbirt; C A Dinarello; M Rubinstein; Z M Sthoeger
Journal:  J Clin Immunol       Date:  2008-07-02       Impact factor: 8.317

6.  Tumor necrosis factor-{alpha} downregulates intestinal NHE8 expression by reducing basal promoter activity.

Authors:  Hua Xu; Huacong Chen; Jiali Dong; Jing Li; Rongji Chen; Jennifer K Uno; Fayez K Ghishan
Journal:  Am J Physiol Cell Physiol       Date:  2008-12-24       Impact factor: 4.249

Review 7.  Overview of the IL-1 family in innate inflammation and acquired immunity.

Authors:  Charles A Dinarello
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

Review 8.  Current stage in inflammatory bowel disease: What is next?

Authors:  Gonzalo Jesús Gómez-Gómez; Ángeles Masedo; Carmen Yela; Maria del Pilar Martínez-Montiel; Begoña Casís
Journal:  World J Gastroenterol       Date:  2015-10-28       Impact factor: 5.742

9.  Unusual water-mediated antigenic recognition of the proinflammatory cytokine interleukin-18.

Authors:  Maria A Argiriadi; Tao Xiang; Chengbin Wu; Tariq Ghayur; David W Borhani
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

10.  Tumor necrosis factor-alpha impairs intestinal phosphate absorption in colitis.

Authors:  Huacong Chen; Hua Xu; Jiali Dong; Jing Li; Fayez K Ghishan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-02-05       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.